Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD20 Rituximab297 anti-Human, RY586, Clone: Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb), BD OptiBuild™
Biosimilar Monoclonal Antibody
Supplier: BD Biosciences 756479
Description
CD20 Rituximab297 Monoclonal antibody specifically detects CD20 Rituximab297 in Human samples. It is validated for Flow cytometry![TRUSTED_SUSTAINABILITY](/content/dam/fishersci/glyphs/Sustain_Badge.png)
Specifications
CD20 Rituximab297 | |
Monoclonal | |
0.2 mg/mL | |
Aqueous buffered solution containing ≤0.09% sodium azide. | |
Human CD20 | |
50 μg | |
Primary | |
Human | |
Liquid |
Flow Cytometry | |
Rituximab297.rMAb (also known as Rituximab N297A Biosimilar.rMAb) | |
RY586 | |
B1; Bp35; LEU-16; MS4A1 | |
Affinity Chromatography | |
RUO | |
931 | |
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated to the dye under optimum conditions that minimize unconjugated dye and antibody. | |
IgG1 κ |
Provide Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction